Actively Recruiting
Prophylactic Minimally Invasive Surfactant Evaluation
Led by Endeavor Health · Updated on 2025-08-07
200
Participants Needed
1
Research Sites
186 weeks
Total Duration
On this page
Sponsors
E
Endeavor Health
Lead Sponsor
C
Chiesi USA, Inc.
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to explore the question: Does prophylactic administration of exogenous surfactant in the delivery room, using a minimally-invasive technique, improve outcome in preterm infants 22-29 weeks' gestation compared to rescue treatment using the same technique?
CONDITIONS
Official Title
Prophylactic Minimally Invasive Surfactant Evaluation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Gestational age less than 30 weeks
- Antenatal consent from parent
You will not qualify if you...
- Presence of congenital anomalies
- Alternate cause of respiratory distress
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Northshore University Healthsystem
Evanston, Illinois, United States, 60201
Actively Recruiting
Research Team
M
Matthew Derrick, MBBS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here